TrialBiometrics2023
DROID: dose-ranging approach to optimizing dose in oncology drug development.
Beibei Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papertrialcites it
TrialBiometrics2023
Beibei Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.